← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 30, 2019Last known activity
Dec 31, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT04186598Lead sponsorN/ADec 31, 2019
- NCT04186598Overall official - principal investigatorN/ADec 31, 2019
- NCT04186598Reponsible party - principal investigatorN/ADec 31, 2019
- NCT03928015Lead sponsorPhase 2Apr 30, 2019
- NCT03928015Reponsible party - principal investigatorPhase 2Apr 30, 2019
Details
- Last known activity
- Dec 31, 2019